William F. Doyle

Insider Reports History

Location
Portsmouth, NH
Signature
Steven Robbins, as attorney in fact for Doyle, William F
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William F. Doyle:

Form 4 holding Executive Chairman, Director

NovoCure Ltd

Security class
Ordinary Shares
Shares / value
328,397
Estimated value
$4,409,977
Report date
03 Mar 2026
Price
$13.43
Ownership
Direct
Form 4 holding Director

Elanco Animal Health Inc

Security class
Common Stock
Shares / value
94,499
Estimated value
$1,403,291
Report date
29 Nov 2024
Price
$14.85
Ownership
Direct
Form 4 holding Executive Chairman, Director

NovoCure Ltd

Security class
Stock Option (Right to Buy)
Shares / value
288,517
Estimated value
Report date
03 Mar 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

Minerva Neurosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
2,500
Estimated value
Report date
10 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by William F. Doyle

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .